Merger with MabVax Therapeutics, Inc. (Tables)

12 Months Ended

Dec. 31, 2014

Business Combinations [Abstract]

Schedule of Estimated Purchase Price of Acquisition

The total estimated purchase price of the acquisition as of July 8, 2014 is as follows:

Purchase Consideration:

(In thousands)
Purchase Consideration			$	6,416
Telik Assets:
Cash and Cash Equivalents	$	1,497
Accounts Receivable		31
Prepaids and Other Current Assets		182
				(1,710	)
Telik Liabilities:
Accrued Compensation	$	850
Accrued Liabilities		111
Accrued Contingent Termination Fee		591
Warrant Liability		568
				2,120
Goodwill			$	6,826